Patients on Medications Metabolized Via CYP450
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Primex PharmaceuticalsSwitzerland - Zug
1 programEvaluation of Primex's PGX Assay to Assess the Clinical Utility of PharmacogenomicsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Primex PharmaceuticalsEvaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics
Clinical Trials (1)
Total enrollment: 100,000 patients across 1 trials
NCT02336269Primex PharmaceuticalsEvaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics
Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics
Start: Oct 2013Est. completion: Oct 2019100,000 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.